A recent development in treating pancreatic cancer offers new hope. After extensive research, an innovative experimental drug has emerged, taken once a day. This drug is showing effectiveness in prolonging the lives of patients.
By focusing on slowing the progression of pancreatic cancer, which is known for its low survival rates, this drug could change the outlook for many individuals diagnosed with the disease.
Dr. Rachna Shroff, who serves as the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, contributes insights to the ongoing efforts in combating this cancer.
In an interview with Stephanie Sy, PBS News Hour correspondent, Dr. Shroff discusses the implications of this breakthrough. Stephanie Sy, a seasoned journalist, has extensive experience with PBS News Hour, Al Jazeera America, CNN International, and other major news outlets. Her reporting has covered significant events, including the 2018 Midterm Elections and providing live reports from key political moments.
Navigating Aging Parents: Encouraging Activity and Engagement 
France’s Heat Wave Causes Spike in Deaths Amidst Europe’s Record Temperatures 
Coping With My Mother’s Alzheimer’s: A Journey of Love and Loss 
Leafy Greens Linked to Improved Lung Health 
Social Media Safety Advocacy 
Hunters Consider Lyme Disease Vaccine Amid Tick Season Challenges